Genomic Valley Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 0.67525 million compared to INR 0.205 million a year ago. Revenue was INR 0.67525 million compared to INR 0.285 million a year ago. Net income was INR 0.232139 million compared to INR 0.614646 million a year ago. Basic earnings per share from continuing operations was INR 0.08 compared to INR 0.2 a year ago. Diluted earnings per share from continuing operations was INR 0.08 compared to INR 0.2 a year ago.
For the six months, sales was INR 1.26 million compared to INR 10.54 million a year ago. Revenue was INR 1.28 million compared to INR 10.77 million a year ago. Net income was INR 0.500244 million compared to INR 5.21 million a year ago. Basic earnings per share from continuing operations was INR 0.16 compared to INR 1.7 a year ago. Diluted earnings per share from continuing operations was INR 0.16 compared to INR 1.7 a year ago.